ONCOmmunity

Found 15815 articles

SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma.

SERPINE1 and SMA were superior to MRI for the detection of ECS. »
05/07/14

Cucurbitacin I inhibits cell migration and invasion and enhances chemosensitivity in colon cancer.

Activity of cucurbitacin I accomplished by downregulating p-STAT3 and MMP-9 expression. »
11/07/14

The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.

Anti-human IL-6 receptor monoclonal antibody or Notch 3 inhibition may be superior to STAT3 inhibition. »
09/30/14

Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin-like growth factor 2 imprinting.

HCT-8 and HT-29 infected with Ad312-EGFP then produced the EGFP. »
11/07/14

miR-340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator.

miR-340 as a tumor suppressor that functions in GIC to enforce PLAT blockade. »
01/29/15

Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study.

Compared to radiation alone or radiation/cisplatin therapy, there was significantly higher cytotoxicity and a greater antitumoral effect with added hormone. »
08/31/14

Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses.

G6PD down-regulation induced poor proliferation and more apoptosis of HPV18 + Hela cells. »
01/25/15

Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapy.

Long-term estrogen-deprived women given exogenous physiologic estrogen have a decreased incidence of breast cancer and decreased mortality. »
11/01/14

Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells.

Ad-HER2-ECD can efficiently transduce HER2-ECD into HER2-negative human cancer cells. »
09/19/14

The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2(+) breast cancer cells.

Observed decrease in CSC marker expression occurred prior to and after telomere shortening. »
11/13/14

< Prev Next >